US Patent 7326535 Immunoreactive peptides from Epstein-Barr virus
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+238 characters)
Article
Patent abstract
Epstein-Barr virus (EBV) specific polypeptides are disclosed. Also disclosed are the use of these polypeptides for the production of polypeptide-specific antibodies and the diagnosis and treatment of EBV-associated disease.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07326535 Immunoreactive peptides from Epstein-Barr virus US Patent 7326535 Immunoreactive peptides from Epstein-Barr virus
Infobox
Patent Number
0732653500
Patent Number
732653500
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073265350
Date of Patent
February 5, 2008
0Patent Application Number
104424560
Date Filed
May 21, 2003
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073265350
Date of Patent
February 5, 2008
0Patent Application Number
104424560
Date Filed
May 21, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07326535 Immunoreactive peptides from Epstein-Barr virus
Infobox
Is a
Patent jurisdiction
Patent number
07326535
Date of patent
February 5, 2008
Patent application number
10442456
Date Filed
May 21, 2003
Patent primary examiner
Find more entities like US Patent 7326535 Immunoreactive peptides from Epstein-Barr virus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
